Search

everythinglearnresearchcommunity

for

Search:↓

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Low-dose dutasteride effectively and safely promotes hair growth in men.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

A new model uses specific blood markers to predict if children's hair loss will return.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

PRP treatment may help with alopecia areata, especially in newer cases.

A girl with Becker naevus syndrome has a genetic variant in the ACTB gene related to her symptoms.

New drugs for alopecia areata show promise but aren't universally effective, and hair loss often returns after stopping treatment.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

Alopecia areata causes negative emotions and stress due to hair loss and emotional triggers.

TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.